Stay updated on Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.

Latest updates to the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedTaoyuan District, Taiwan was removed from the locations and Taoyuan, Taiwan was added. This updates the listed trial site to reflect a city designation instead of the district.SummaryDifference0.0%

- Check19 days agoChange DetectedThe page now includes 'Multiple myeloma' as a keyword and adds a related topics section that references MedlinePlus Genetics. The revision tag shows the page updated to v3.5.3 (replacing v3.5.2).SummaryDifference0.1%

- Check26 days agoChange DetectedAdded: Revision: v3.5.2. Deleted: Multiple myeloma, related topics:, MedlinePlus Genetics, Revision: v3.5.0.SummaryDifference0.1%

- Check48 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the related topics section.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated to v3.5.0; previous revision v3.4.3 was removed.SummaryDifference0.0%

- Check62 days agoChange DetectedRemoved the 'Multiple myeloma' topic and the related 'MedlinePlus Genetics' section from the page.SummaryDifference0.1%

Stay in the know with updates to Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab Combo Vs Lenalidomide in Myeloma Clinical Trial page.